Alcoholic hepatitis CT

Jump to navigation Jump to search

Alcoholic hepatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Alcoholic hepatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic hepatitis CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alcoholic hepatitis CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic hepatitis CT

CDC on Alcoholic hepatitis CT

Alcoholic hepatitis CT in the news

Blogs on Alcoholic hepatitis CT

Directions to Hospitals Treating Alcoholic hepatitis

Risk calculators and risk factors for Alcoholic hepatitis CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

CT scan is usually performed among patients with Alcoholic Hepatitis to exclude other abnormalities including neoplasm, biliary obstruction or infiltrative liver disease.CT scan can predict severity and outcome of Alcoholic Hepatitis by presence of splenomegaly, ascites, varices, liver length to mid clavicular line, decreased liver attenuation, liver to spleen attenuation ratio and increased liver heterogenecity.

CT

References

  1. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L (1991). "Prognostic factors in alcoholic liver disease. VA Cooperative Study Group". Am J Gastroenterol. 86 (2): 210–6. PMID 1992635.
  2. Suk KT (2014). "Hepatic venous pressure gradient: clinical use in chronic liver disease". Clin Mol Hepatol. 20 (1): 6–14. doi:10.3350/cmh.2014.20.1.6. PMC 3992331. PMID 24757653.
  3. Bloom PP, Mojtahed A, Bethea ED, Knooihuizen SA, Choi J, Dienstag JL; et al. (2020). "Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes". Dig Dis Sci. 65 (1): 312–321. doi:10.1007/s10620-019-05721-4. PMID 31363954.
  4. Maruzzelli L, Parr AJ, Miraglia R, Tuzzolino F, Luca A (2014). "Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation". Acad Radiol. 21 (4): 507–13. doi:10.1016/j.acra.2014.01.007. PMID 24594420.
  5. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW; et al. (2006). "Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment". Radiology. 239 (1): 105–12. doi:10.1148/radiol.2391050361. PMID 16484355.
  6. Lee JY, Kim TY, Jeong WK, Kim Y, Kim J, Kim KW; et al. (2014). "Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis". Dig Dis Sci. 59 (9): 2333–43. doi:10.1007/s10620-014-3149-8. PMID 24723070.
  7. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980). "Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease". Radiology. 137 (3): 727–9. doi:10.1148/radiology.137.3.6934563. PMID 6934563.

Template:WikiDoc Sources